Last edition
News about "anxiety disorders"
US FDA Approves Lupin's Generic Diazepam Injection in Prefilled Syringe Format
Lupin has secured US FDA approval for its generic diazepam injection USP in a single-dose prefilled syringe format. The bioequivalent version of Roche's Valium injection expands the company's US injectable portfolio and addresses a market valued at nearly USD 78 million annually.
Anxiety Disorders | 04/08/2026 | By News Bureau
Leiutis Pharma Announces CDSCO Approval for World's First Synthetic CBD Anxiety Therapy
Leiutis Pharmaceuticals has received CDSCO approval for the world's first synthetic CBD oral solution to treat mild to moderate anxiety disorders alongside cognitive behavioral therapy.
Anxiety Disorders | 15/07/2026 | By News Bureau | 1805
Silo Pharma Signs LOI with Allucent for Phase I Development of SPC-15
Silo Pharma has executed a Letter of Intent (LoI) with Allucent to support the phase I clinical development of SPC-15, with planned single-ascending dose and multiple-ascending dose studies representing a key clinical milestone for its intranasal treatment targeting PTSD and anxiety disorders.
Anxiety Disorders | 31/12/2025 | By News Bureau | 215
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy